ulcerative colitis (uc)
Showing 1 - 25 of 29
Chinese Spondyloarthritis Inception Cohort (CESPIC)
Not yet recruiting
- Ankylosing Spondylitis (AS) / Radiographic Axial SpA (r-axSpA)
- +6 more
- (no location specified)
Jul 25, 2023
Ulcerative Colitis (UC) Trial in Puerto Rico, United States (Mesalamine, Placebo)
Not yet recruiting
- Ulcerative Colitis (UC)
- Mesalamine
- Placebo
-
Washington, District of Columbia
- +9 more
Nov 21, 2022
Ulcerative Colitis (UC) Trial in Stockholm (TLA Gut™)
Recruiting
- Ulcerative Colitis (UC)
- TLA Gut™
-
Stockholm, SwedenErsta Sjukhus, Medicinkliniken
Nov 7, 2022
Ulcerative Colitis (UC), Crohn's Disease Trial in Germany, Israel, United States (Risankizumab, Cytochrome P450 (CYP)
Completed
- Ulcerative Colitis (UC)
- Crohn's Disease
- Risankizumab
- Cytochrome P450 (CYP) Substrates
-
Coronado, California
- +5 more
Oct 20, 2022
Ulcerative Colitis (UC) Trial in Guangzhou (Placebo, IBI112)
Recruiting
- Ulcerative Colitis (UC)
- Placebo
- IBI112
-
Guangzhou, Guangdong, ChinaFirst Affiliated Hospital of Sun Yat-sen University
Sep 20, 2022
Ulcerative Colitis (UC) Trial in Worldwide (risankizumab IV, for risankizumab, risankizumab SC)
Recruiting
- Ulcerative Colitis (UC)
- risankizumab IV
- +2 more
-
Coronado, California
- +429 more
Aug 11, 2022
Ulcerative Colitis (UC) Trial in Worldwide (Placebo, Upadacitinib)
IBD (IBD), Crohn Disease (CD), Ulcerative Colitis (UC) Trial in Worldwide
Recruiting
- Inflammatory Bowel Diseases (IBD)
- +2 more
-
Aabenraa, Denmark
- +16 more
Jun 9, 2022
Ulcerative Colitis (UC) Trial in Philadelphia, Halifax, Holon (Ulcerative Colitis Diet, Antibiotic cocktail)
Completed
- Ulcerative Colitis (UC)
- Ulcerative Colitis Diet
- Antibiotic cocktail
-
Philadelphia, Pennsylvania
- +2 more
May 29, 2022
Ulcerative Colitis (UC) Trial in Worldwide (risankizumab, for risankizumab)
Enrolling by invitation
- Ulcerative Colitis (UC)
- risankizumab
- placebo for risankizumab
-
Coronado, California
- +423 more
May 26, 2022
Crohn Disease (CD), Ulcerative Colitis (UC), Indeterminate Colitis Trial in New York (Vaccine Education)
Enrolling by invitation
- Crohn Disease (CD)
- +2 more
- Vaccine Education
-
New York, New YorkWeill Cornell Medicine
Mar 24, 2022
Ulcerative Colitis (UC) Trial in Worldwide (ABBV-323 Dose A, ABBV-323 Dose B)
Completed
- Ulcerative Colitis (UC)
- ABBV-323 Dose A
- ABBV-323 Dose B
-
Tucson, Arizona
- +33 more
Mar 10, 2022
Adalimumab for Treating Ulcerative Colitis in Real Life
Active, not recruiting
- Ulcerative Colitis (UC)
-
Nice, Alpes-Maritimes, France
- +79 more
Feb 15, 2022
Ulcerative Colitis (UC) Trial in Worldwide (Placebo, Upadacitinib)
Humira® in Moderately to Severely Active Ulcerative Colitis
Active, not recruiting
- Ulcerative Colitis (UC)
-
Birmingham, Alabama
- +512 more
Jan 24, 2022
Ulcerative Colitis (UC) Trial in Worldwide (Upadacitinib (ABT-494), Placebo)
Active, not recruiting
- Ulcerative Colitis (UC)
- Upadacitinib (ABT-494)
- Placebo
-
Mobile, Alabama
- +490 more
Jan 18, 2022
Ulcerative Colitis (UC) Trial in Worldwide (TD-1473 Dose A, TD-1473 Dose B, TD-1473 Dose C)
Terminated
- Ulcerative Colitis (UC)
- TD-1473 Dose A
- +2 more
-
Chula Vista, California
- +183 more
Nov 16, 2021
Ulcerative Colitis (UC) Trial in Worldwide (TD-1473 Dose A, TD-1473 Dose B, TD-1473 Dose C)
Terminated
- Ulcerative Colitis (UC)
- TD-1473 Dose A
- +3 more
-
Chula Vista, California
- +187 more
Nov 16, 2021
German Spondyloarthritis Inception Cohort
Recruiting
- Ankylosing Spondylitis (AS) / Radiographic Axial SpA (r-axSpA)
- +5 more
-
Berlin, GermanyCharité - Universitätsmedizin Berlin
Oct 5, 2021
Inflectra In Patients With Inflammatory Bowel Disease
Completed
- Inflammatory Bowel Disease (IBD)
- +2 more
-
San Diego, California
- +14 more
Feb 8, 2021
IBD (IBD), Crohn's Disease (CD), Ulcerative Colitis (UC) Trial in Kansas City (Fecal Microbiota Transplantation (FMT))
Completed
- Inflammatory Bowel Diseases (IBD)
- +2 more
- Fecal Microbiota Transplantation (FMT)
-
Kansas City, MissouriChildren's Mercy Hospital
Feb 2, 2021
Ulcerative Colitis (UC) Trial in Worldwide (Adalimumab, Placebo)
Autoimmune Diseases, IBD, Crohn Disease (CD) Trial in Odense (Intake of red and processed meat and fibres, Lifestyle factors
Active, not recruiting
- Autoimmune Diseases
- +8 more
- Intake of red and processed meat and fibres
- Lifestyle factors independently or combined
-
Odense, DenmarkUniversity of Southern Denmark
Nov 6, 2020
Faecal Calprotectin asPotential Non-invasive Inflammatory Marker
Completed
- Inflammatory Bowel Disease (IBD)
- +3 more
-
Wolverhampton, United KingdomThe Royal Wolverhampton NHS Trust
Mar 26, 2020
A Blood and Tissue Sample Collection Study of Inflammatory Bowel
Withdrawn
- Crohn's Disease
- +2 more
-
Pisa, ItalyAOU Pisana /ID# 208952
Nov 20, 2019